DEMARZO , Maria Giulia

Last name: DEMARZO

First name: Maria Giulia

May 28, 2024 (v1)

Publication

Metadata-only

Reduction of fecal calprotectin levels induced by a short-course of Escherichia coli Nissle is associated with a lower likelihood of disease flares in patients with ulcerative colitis in clinical remission

DEMARZO, MARIA GIULIA

Background and aim: Fecal Calprotectin (FC) is a biomarker of gut inflammation, and Escherichia coli Nissle 1917 (EcN) is a probiotic strain able to reduce gut inflammation and maintain disease remission in patients with Inflammatory Bowel Disease (IBD). The aim is to assess the effects of EcN administration in patients with IBD in clinical...

Uploaded on: July 3, 2024
2019 (v1)

Publication

Metadata-only

Reproducibility and transportability of the absence of incremental infectious adverse events in patients with higher anti-TNF drug levels

Giannini EG DEMARZO, MARIA GIULIA Bodini G

No description

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease

BODINI, GIORGIA DEMARZO, MARIA GIULIA SARACCO, MARGHERITA

Objectives: Up to 40% of inflammatory bowel disease (IBD) patients treated with anti-TNF drugs lose response within 1 year of treatment, therefore requiring drug optimization. Although higher drug trough levels (TLs) are associated with sustained clinical outcomes, there are concerns that they may be associated with a higher risk of adverse...

Uploaded on: April 14, 2023

DEMARZO , Maria Giulia

Recent uploads